Fangjie Yan

1.0k total citations
23 papers, 742 citations indexed

About

Fangjie Yan is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Fangjie Yan has authored 23 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cell Biology and 7 papers in Cancer Research. Recurrent topics in Fangjie Yan's work include Ubiquitin and proteasome pathways (10 papers), Hippo pathway signaling and YAP/TAZ (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Fangjie Yan is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Hippo pathway signaling and YAP/TAZ (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Fangjie Yan collaborates with scholars based in China, Macao and New Zealand. Fangjie Yan's co-authors include Qiaojun He, Hong Zhu, Bo Yang, Tao Yuan, Ji Cao, Meidan Ying, Meijia Qian, Xiaoyang Dai, Tianyi Zhou and Xiaowu Dong and has published in prestigious journals such as Hepatology, Cancer Research and The FASEB Journal.

In The Last Decade

Fangjie Yan

21 papers receiving 736 citations

Peers

Fangjie Yan

ONCOL

PRM

Travis J. Yates United States

Ailing W. Scott United States

Xuhong Fu China

Kumaresan Ganesan India

Elizabeth Alli United States

Chloé Sauzay France

Hyo Won Chang South Korea

Rick Lesniewski United States

Debottam Sinha Australia

Shou-Ching Tang United States

Travis J. Yates United States

Fangjie Yan

439 ×0.8

193 ×0.9

ONCOL

217 ×1.1

183 ×1.5

108 ×1.5

PRM

Citations per year, relative to Fangjie Yan Fangjie Yan (= 1×) peers Travis J. Yates

Countries citing papers authored by Fangjie Yan

Since Specialization

Citations

This map shows the geographic impact of Fangjie Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangjie Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangjie Yan more than expected).

Fields of papers citing papers by Fangjie Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangjie Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangjie Yan. The network helps show where Fangjie Yan may publish in the future.

Co-authorship network of co-authors of Fangjie Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Fangjie Yan. A scholar is included among the top collaborators of Fangjie Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangjie Yan. Fangjie Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiao, Huilin Ma, Fangjie Yan, et al.. (2025). JOSD2 promotes breast cancer metastasis by deubiquitinating and stabilizing SMAD4. Biochemical Pharmacology. 232. 116748–116748. 1 indexed citations

Zhang, Peiying, Xiangning Liu, Yue Liu, et al.. (2025). VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination‐Dependent Degradation. Cancer Science. 116(6). 1579–1591.

Zhang, Yuchen, et al.. (2024). Design, synthesis, and antitumor activity evaluation of potent fourth-generation EGFR inhibitors for treatment of Osimertinib resistant non-small cell lung cancer (NSCLC). Bioorganic Chemistry. 147. 107394–107394. 8 indexed citations

Cheng, Mengting, Fei Wang, Zhifei Xu, et al.. (2024). Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma. Expert Opinion on Drug Metabolism & Toxicology. 20(9). 907–922.

Wang, Sijie, et al.. (2024). Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement. Biochemical Pharmacology. 227. 116463–116463. 4 indexed citations

Wang, Jiao, Tao Yuan, Meijia Qian, et al.. (2022). The molecular mechanisms and targeting strategies of transcription factors in cholangiocarcinoma. Expert Opinion on Therapeutic Targets. 26(9). 781–789. 2 indexed citations

Chen, Zibo, Tao Yuan, Fangjie Yan, et al.. (2022). CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling. BMC Cancer. 22(1). 425–425. 11 indexed citations

Qian, Meijia, Fangjie Yan, Weihua Wang, et al.. (2021). Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression. Acta Pharmaceutica Sinica B. 11(12). 4008–4019. 32 indexed citations

Zhu, Hong, Fangjie Yan, Tao Yuan, et al.. (2020). USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ. Cancer Research. 80(11). 2204–2216. 133 indexed citations

10.

Zhu, Hong, Yan Hu, Chenming Zeng, et al.. (2020). The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer. Theranostics. 10(5). 2188–2200. 16 indexed citations

11.

Qian, Meijia, Fangjie Yan, Tao Yuan, et al.. (2020). Targeting post-translational modification of transcription factors as cancer therapy. Drug Discovery Today. 25(8). 1502–1512. 33 indexed citations

12.

Wang, Weihua, Tao Yuan, Meijia Qian, et al.. (2020). Post-translational modification of KRAS: potential targets for cancer therapy. Acta Pharmacologica Sinica. 42(8). 1201–1211. 35 indexed citations

13.

Yan, Fangjie, Meijia Qian, Qiaojun He, Hong Zhu, & Bo Yang. (2019). The posttranslational modifications of Hippo-YAP pathway in cancer. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(1). 129397–129397. 59 indexed citations

14.

Yuan, Tao, Zibo Chen, Fangjie Yan, et al.. (2019). Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein. Molecular Oncology. 14(1). 197–210. 62 indexed citations

15.

Zhu, Hong, Dandan Wang, Tao Yuan, et al.. (2018). Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis. Cancer Research. 78(14). 3995–4006. 34 indexed citations

16.

Yan, Fangjie, et al.. (2018). A novel natural compound Shikonin inhibits YAP function by activating AMPK. 1(3). 136–142. 1 indexed citations

17.

Yuan, Tao, Fangjie Yan, Meidan Ying, et al.. (2018). Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy. Frontiers in Pharmacology. 9. 1080–1080. 113 indexed citations

18.

Zhu, Hong, Linlin Chang, Fangjie Yan, et al.. (2017). AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer. Theranostics. 8(3). 676–692. 71 indexed citations

19.

Wang, Dandan, Ying Chen, Zibo Chen, et al.. (2016). CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation. Molecular Cancer Therapeutics. 15(12). 2916–2925. 38 indexed citations

20.

Zhu, Hong, Ying Chen, Fangjie Yan, et al.. (2016). Polysarcosine brush stabilized gold nanorods for in vivo near-infrared photothermal tumor therapy. Acta Biomaterialia. 50. 534–545. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact